Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said Thursday, according to news agency AFP. \"This is a critical step toward ensuring global access to an urgently needed Covid-19 treatment and we are confident that...the anticipated treatments will be rapidly available in low- and middle-income countries,\" said Charles Gore, executive director of Medicines Patent Pool.<\/div><\/div>","entype":"Text","h":"","img":"","imgalt":"","imgcaption":"","key":"False","link":"","s":20,"sub":"","t":"Jan 20, 2022-17:40:45","title":"
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said Thursday, according to news agency AFP. \"This is a critical step toward ensuring global access to an urgently needed Covid-19 treatment and we are confident that...the anticipated treatments will be rapidly available in low- and middle-income countries,\" said Charles Gore, executive director of Medicines Patent Pool.<\/div>","type":"nfeed"});